Zobrazeno 1 - 10
of 37
pro vyhledávání: '"35"'
Autor:
Binswanger IA; Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado, USA.; Colorado Permanente Medical Group, Aurora, Colorado, USA.; Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Carroll NM; Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado, USA., Ahmedani BK; Henry Ford Health System, Detroit, Michigan, USA., Campbell CI; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Haller IV; Essentia Institute of Rural Health, Essentia, Essentia Health, Duluth, Minnesota, USA., Hechter RC; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., McNeely J; Department of Population Health, New York University School of Medicine, New York, New York, USA., Yarborough BJH; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Kline-Simon AH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Satre DD; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Department of Psychiatry, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA., Weisner C; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Department of Psychiatry, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA., Lapham GT; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.; Department of Health Services, University of Washington School of Public Health, Seattle, Washington, USA.
Publikováno v:
Substance abuse [Subst Abus] 2019; Vol. 40 (3), pp. 292-301. Date of Electronic Publication: 2019 Jan 24.
Autor:
Heerema MR; General Internal Medicine, Boston Medical Center, Boston, MA, USA.; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA., Ventura AS; General Internal Medicine, Boston Medical Center, Boston, MA, USA.; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA., Blakemore SC; General Internal Medicine, Boston Medical Center, Boston, MA, USA.; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA., Montoya ID; General Internal Medicine, Boston Medical Center, Boston, MA, USA.; Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Gobel DE; General Internal Medicine, Boston Medical Center, Boston, MA, USA.; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA., Kiang MV; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA., LaBelle CT; General Internal Medicine, Boston Medical Center, Boston, MA, USA.; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA.; Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Bazzi AR; Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA.; Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, CA, USA.
Publikováno v:
Substance abuse [Subst Abus] 2023 Jul; Vol. 44 (3), pp. 164-176. Date of Electronic Publication: 2023 Jun 07.
Publikováno v:
Substance Abuse. 43:649-656
BACKGROUND Opioid misuse during pregnancy has been associated with adverse infant outcomes including preterm birth, stillbirth, and neonatal opioid withdrawal syndrome. The Pregnancy Risk Assessment Monitoring System (PRAMS) is an on-going state-base
Autor:
Vanessa Jacobsohn, Snehal Bhatt, Larissa A Maley, Andrew L. Sussman, Orrin Myers, Rana S. Alkhafaji, Julie G. Salvador, Heidi Rishel Brakey
Publikováno v:
Subst Abus
Background Buprenorphine combined with psychosocial support is the standard of care for treatment of opioid use disorder (OUD) in office-based primary care settings. However, uptake of this treatment has been slow due to a number of addressable barri
Autor:
Saloner B; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Landis RK; Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University, Washington, District Columbia, USA.; RAND Corporation, Pittsburgh, Pennsylvania, USA., Jayakrishnan R; Herbert Wertheim College of Medicine, Florida International University, Orlando, Florida, USA., Stein BD; RAND Corporation, Pittsburgh, Pennsylvania, USA., Barry CL; Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, New York, USA.
Publikováno v:
Substance abuse [Subst Abus] 2022; Vol. 43 (1), pp. 682-690.
Autor:
Pamela A. Matson, Neha Bakhai, Sarah Flessa, Barry S. Solomon, Christopher J. Hammond, Hoover Adger, Julia V Ramos
Publikováno v:
Subst Abus
BACKGROUND: Children of parents with substance use disorders are at greater risk for mental and physical health co-morbidities. Despite guidelines, pediatricians rarely screen for substance use in the family/household, citing fear of offending parent
Publikováno v:
Substance Abuse. 43:113-126
Background: Communities across the United States are confronting the precipitous rise in opioid overdose fatalities that has occurred over the past decade. Naloxone, an opioid antagonist, is a safe rescue medication that laypeople can administer to r
A Case of Cannabinoid Hyperemesis Syndrome with Heliobacter Pylori and Preeclampsia during Pregnancy
Autor:
Randall T. Kelly, Charles Burns, Madeline Manning Meurer, Natalia Schlabritz-Loutsevitch, Kalyan Chakrala, Dinesh Gowda
Publikováno v:
Substance Abuse. 39:9-13
Background The condition termed cannabinoid hyperemesis syndrome (CHS) was characterized a decade ago by Allen et al. and includes cyclic episodes of nausea and vomiting and the learned behavior of hot bathing in individuals with chronic cannabis abu
Autor:
Elizabeth J. Hagy, Brittany Ratliff, Robert P. Pack, Nicholas E. Hagemeier, Angela Hagaman, Scott Brewster, Fred Tudiver
Publikováno v:
Substance Abuse. 39:89-94
Background Prescribers and community pharmacists commonly perceive prescription opioid abuse to be a problem in their practice settings and communities. Both cohorts have expressed support for interventions that improve interprofessional communicatio
Publikováno v:
Substance Abuse. 38:477-482
Background Online communities can provide social support to those in need and can foster personal empowerment for individuals experiencing distress. This study examines the content of a Reddit community dedicated to the support of people trying to qu